1

5 Simple Statements About ABBV-744 clinical trial phase 1 results Explained

News Discuss 
In Segment A, members will acquire distinct doses and schedules of oral ABBV-744 pill to identify Risk-free dosing program. Extra individuals are going to be enrolled on the determined monotherapy dosign program. In Phase B, contributors will receive oral ruxolitinib and ABBV-744 will likely be supplied as "add-on" therapy. In https://cicerok666yjt9.westexwiki.com/user

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story